홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2-Methylpiperazine, (R)- → N-{5-Chloro-6-[(3R)-3-methyl-piperazin-1-yl]-pyridin-3-ylmethyl}-acetamide

HRID 730870
노트
인쇄 미리보기

반응식

HRID 730870 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([CH2:9][NH:10][C:11](=[O:13])[CH3:12])[CH:5]=[N:6][C:7]=1Cl.[CH3:14][C@@H:15]1[CH2:20][NH:19][CH2:18][CH2:17][NH:16]1>>[Cl:1][C:2]1[CH:3]=[C:4]([CH2:9][NH:10][C:11](=[O:13])[CH3:12])[CH:5]=[N:6][C:7]=1[N:19]1[CH2:18][CH2:17][NH:16][C@H:15]([CH3:14])[CH2:20]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 73304342-Methylpiperazine, (R)-HCID 19959722N-(5,6-Dichloro-pyridin-3-ylmethyl)-acetamide

생성물 1

HCID 67401815N-{5-Chloro-6-[(3R)-3-methyl-piperazin-1-yl]-pyridin-3-ylmethyl}-acetamide

실험 절차

A mixture of N-(5,6-dichloro-pyridin-3-ylmethyl)-acetamide from step (d) above (250 mg, 1.14 mmol) and (R)-(−)-2-methyl-piperazine (126 mg, 1.26 mmol, Aldrich) reacted under the conditions of Example 3a to give the title compound. MS (ESI, pos. ion) m/z: 283 (M+1).

후처리

  1. customreacted under the conditions of Example 3a

출처 및 근거

ORD 기록
ord-402a088df749452e8f7cacb644a5ece6
출처 데이터셋
uspto-grants-2009_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07582761B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트